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Background
The diagnostic performance of cardiac magnetic reso-
nance (CMR) imaging in suspected myocarditis is still
limited. Recently, CMR T1 and T2 mapping has been
suggested to yield excellent diagnostic accuracies in
patients with suspected myocarditis as compared to
healthy controls. However, the true diagnostic perfor-
mance of CMR mapping when compared to endomyo-
cardial biopsy (EMB) and the impact of CMR field
strength in patients with a variety of pathologies is still
unknown and was therefore assessed in this study.
Methods
Within the final analyses, 129 consecutive patients with
suspected acute or chronic myocarditis were included.
Patients had to fulfill indications for CMR imaging
according to the JACC White consensus paper.
All patients underwent biventricular EMB, cardiac
catheterization for exclusion of coronary artery disease,
and CMR on a 1.5 (Intera, CV, Philips Medical Systems,
Best, The Netherlands) and 3.0 (Magnetom Verio, Sie-
mens Healthcare, Erlangen, Germany) Tesla tomography.
The CMR protocol included standard Lake-Louise (LL)
parameters as well as native and post contrast T1 and T2
mapping. Relative Enhancement was assessed with a T1
weighted TSE sequence, edema ratio with a T2 weighted
STIR sequence. T1 Mapping was measured with a
MOLLI-Sequence pre and post contast (0.015 mmol
Gadobutorol per kg body weight (Gadovist, Bayer
Healthcare, Leverkusen, Germany) and T2 Mapping with
a Multi Echo Spin Echo sequence on the 1.5T scanner
and a T2 prepared SSFP sequence on the 3T scanner.
Patients were divided into 2 groups according to duration
of symptoms: patients with acute symptoms (≤14 days)
and those with chronic symptoms (>14 days).
Results
The diagnostic performance of LL criteria, native T1 and
extracellular volume fraction (ECV) as well as T2 mapping
is summarized in the table. On 1.5 Tesla, in patients with
acute symptoms, native T1 yielded best diagnostic perfor-
mance (81%) followed by ECV (75%) and T2 (72%). In
chronic patients, T2 was the only technique achieving an
acceptable accuracy (72%). Accuracies of imaging techni-
ques on 3.0 Tesla CMR were slightly lower as compared
to 1.5 Tesla. However, T2 mapping on 3.0 Tesla appeared
to be unsatisfactory for the diagnosis of myocarditis.
Conclusions
In patients with acute symptoms and suspected myocar-
ditis, mapping techniques provides a useful tool for the
confirming or rejecting the diagnosis of myocarditis and
are superior to LL criteria. In contrast, only T2 mapping
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with chronic symptoms. The impact of field strength on
diagnostic accuracies requires further exploration.
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